Annual report
4598.TEDINET S100R4T2
Period2022-04-01 → 2023-03-31
Filed2023-06-26
StandardJapan GAAP
ConsolidatedNo
Data checks11 of 11 passed
Key figures · 72
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥1.3bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | −¥961m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | −¥1.3bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥964m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥859m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.6bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥671m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.3bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥964m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | −¥1.3bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥967m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | −¥863m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥674m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥907m | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥1.3bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥2.2bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.6bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥116m | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥91m | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥791m | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.1bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥2.1bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.5bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥844m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥844m | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2021-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.5bn | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥1.3bn | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥940m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥727m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥585m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥326,000 | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥505,000 | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥13m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥883m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥120m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥875m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥100m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.3bn | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-234.51 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-178.58 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-187.34 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-348.32 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-170.16 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥123.91 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥227.41 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥390.87 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥456.47 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥801.93 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 87.0% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.1% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.1% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.1% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 98.2% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 6,369,600 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,419,600 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,314,600 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,504,600 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,369,600 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 11 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 12 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 11 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 13 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 11 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 717
| Item | Context | Value | Unit |
|---|---|---|---|
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)四国財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-06-26 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第13期(自 2022年４月１日 至 2023年３月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)Ｄｅｌｔａ－Ｆｌｙ Ｐｈａｒｍａ 株式会社 | |
| Company name in english cover page | FilingDateInstant | Ｄｅｌｔａ－Ｆｌｙ Ｐｈａｒｍａ, Ｉｎｃ． | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 江島 淸 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)徳島県徳島市川内町宮島錦野37番地の５ | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)088－637－1055(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 管理部門担当 黒滝 健一 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都中央区日本橋本町３丁目11番５号日本橋ライフサイエンスビルディング２ ６階 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03－6231－1278 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 管理部門担当 黒滝 健一 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E34318 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45980 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)Ｄｅｌｔａ－Ｆｌｙ Ｐｈａｒｍａ 株式会社 | |
| Filer name in english | FilingDateInstant | Delta-Fly Pharma,Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2023-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2022-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Risk management (text) | FilingDateInstant | Text · Plus | |
| Reference to other information risk management | FilingDateInstant | Original text (Japanese)３ 事業等のリスク |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |